Angioma serpiginosum successfully treated by a single session of intense pulsed light therapy
Authors
Abstract:
Angioma serpiginosum (AS) is a nevoid capillary malformation developed congenitally or thereafter. The AS stops growing after puberty and may remain persistent throughout life. The pulsed dye laser (PDL) and KTP are used to treat the AS usually after several sessions. We treated a patient with AS with only one session of intense pulsed light (IPL) therapy. A 40-year-old lady with Fitzpatrick skin type 3 and AS on the left maxillary and infraorbital area was scheduled to be treated with IPL. The lesion was treated by a single pass of IPL therapy with 8 joules/ cm2, in the telangiectatic mode. No anesthesia more than cooling was used, and a mild erythema was developed immediately after IPL therapy, which subsided soon after the procedure. Two months later, telangiectatic lagoons were completely removed, and only very faint erythema remained. IPL is an effective and more tolerable device for the treatment of AS, with no purpura and discoloration, as frequently observed following PDL therapy.
similar resources
Intense Pulsed Light Therapy
Intense pulsed light (IPL) is one of the most effective nonablative approaches to treat skin photoaging. The broad range of wavelengths (500–1200 nm) emitted from IPL devices effectively target both melanin and hemoglobin in the skin. Numerous trials show the effectiveness and compatibility of IPL devices in a variety of skin conditions, especially in cosmetic indications such as hypertrichosis...
full textPigmentation due to stasis dermatitis treated successfully with a noncoherent intense pulsed light source.
A 69-year-old Caucasian female consulted our department for treatment of pigmentary ochre dermatitis secondary to a chronic venous insufficiency of 25 years’ duration. She presented purpuric macules and patches, ochre-brownish in color, on the lower third of both legs with no discomfort except her aesthetic problem (Figure 1). The patient made no reference to taking any medication or to having ...
full textAtypical Angioma Serpiginosum
Angioma serpiginosum is an uncommon, acquired vascular nevoid disorder with capillary dilation and proliferation in the papillary dermis. The eruptions are asymptomatic and characterized by grouped, erythematous to violaceous, serpiginous and punctate macules. The condition usually appears in females during adolescence on unilateral lower extremities and the buttocks. We report a rare case with...
full text[Intense pulsed light therapy for lupus pernio].
71 in 2008 in which Diaz et al 9 described a patient treated with adalimumab for rheumatoid arthritis whose lesions developed 2 months after the start of biologic treatment; and the third reported by Adenis-Lamarre et al 10 in 2009 in a patient with rheumatoid arthritis receiving adalimumab who developed skin lesions and was subsequently diagnosed with M chelonae infection. Our case differs fro...
full textDermoscopy of acral angioma serpiginosum.
Angioma serpiginosum (AS) is an unusual vascular disorder that typically affects female patients, begins in childhood and stabilizes in adulthood and not frequently involve acral skin. We herein present a 13 year-old girl with an asymptomatic erythematous punctuate first noticed on the right palm three years ago, with a proximal serpiginous progression up to the forearm. On examination there wa...
full textEfficacy of the intense pulsed light source on unwanted hairs
Background: The need for a rapid, non-invasive method for unwanted hair removal has led to the development of various light sources for this purpose. Objective: To evaluate the efficacy of Intense Pulsed Light Source (IPLS) on unwanted hairs. Patients and Methods: In this open, uncontrolled clinical trial, 77 different anatomical areas in 34 referred patients to “Novin Didegan Clinic” in Tehran...
full textMy Resources
Journal title
volume 21 issue 2
pages 62- 64
publication date 2018-06-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023